Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30

Inovio's (INO) DNA Technology Platform Further Validated with Latest Qtr. Results - Stifel

November 9, 2015 2:46 PM EST

Stifel affirms its Buy rating and $19 price target on Inovio (Nasdaq: INO) following the company's Q3 report and update issued earlier Monday.

Analyst Thomas Shrader, PhD, CFA, noted that EPS of $0.07 was flat with consensus estimates and revenue was driven by... More

Inovio Pharma (INO) Swings to Q3 Profit

November 9, 2015 6:28 AM EST

Inovio Pharma (NASDAQ: INO) reported Q3 EPS of $0.07, versus ($0.12) reported last year. Revenue for the quarter came in at $24.18 million, versus $1.84 million reported last year.

For earnings history and earnings-related data on Inovio Pharma (INO) click here.

... More